Elite in Relapsing Polychondritis

Simona Rednic

Umf
Cluj-napoca, CJ, RO 
Elite in Relapsing Polychondritis
Umf
Cluj-napoca, CJ, RO 
OverviewLocationsClinical Research

Overview

Simona Rednic practices in Cluj-napoca, Romania. Ms. Rednic is rated as an Elite expert by MediFind in the treatment of Relapsing Polychondritis. Her top areas of expertise are Relapsing Polychondritis, Systemic Sclerosis (SSc), Scleroderma, and Arthritis.

Her clinical research consists of co-authoring 98 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Relapsing Polychondritis.

Gender
Female

Locations

UMF
Cluj-napoca, CJ, Romania

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

98 Total Publications

Monosodium urate crystals exposure is associated with limited transcriptional changes in primary human PBMCs.
Monosodium urate crystals exposure is associated with limited transcriptional changes in primary human PBMCs.
Journal: Romanian journal of internal medicine = Revue roumaine de medecine interne
Published: August 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Rednic's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 49 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile